IDH2 and central nervous system cancer: LGG in ‘adult-type’ diffuse gliomas is used for isocitrate dehydrogenase (IDH) 1 and 2 mutant tumors or IDH-wildtype gliomas exhibiting molecular features of high-grade gliomas and usually progressing to glioblastoma histology (Komori 2021).